Moderna (LIM:MRNA) ROE % Adjusted to Book Value : 2.36% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Moderna ROE % Adjusted to Book Value?

Moderna's ROE % for the quarter that ended in Dec. 2023 was 6.36%. Moderna's PB Ratio for the quarter that ended in Dec. 2023 was 2.70. Moderna's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 2.36%.

Moderna ROE % Adjusted to Book Value Historical Data

The historical data trend for Moderna's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna ROE % Adjusted to Book Value Chart

Moderna Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.23

21.55

11.88

-10.59

Moderna Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															7.47	0.59	-9.91	-33.63	2.36

Competitive Comparison of Moderna's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Moderna's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Moderna's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Moderna's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Moderna's ROE % Adjusted to Book Value falls into.

Moderna ROE % Adjusted to Book Value Calculation

Moderna's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-28.59%	/	2.70
	=	-10.59%

Moderna's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	6.36%	/	2.70
	=	2.36%

Moderna ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Moderna's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Moderna (LIM:MRNA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (LIM:MRNA) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

MRNA:USA MRNA:Mexico 0QFd:UK 0A45:UK 0QF:Germany M1RN34:Brazil MRNA:Austria

Address

200 Technology Square, Cambridge, MA, USA, 02139

Website

https://www.modernatx.com

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.